Outlook on the Single-use Technologies for Biopharmaceuticals Global Market to 2026 - Increasing Demand for Personalized Medicine is Driving Growth

News provided by

May 27, 2022, 13:30 ET

DUBLIN, May 27, 2022 /PRNewswire/ -- The "Single-use Technologies for Biopharmaceuticals: Global Markets" report has been added to ResearchAndMarkets.com's offering.

The report summarizes the market, including a market snapshot and company profiles of key players in the sole-use technologies market. It provides a comprehensive market breakdown with in-depth information about each segment. The overview section of the report describes market trends and dynamics, including drivers, limitations, challenges, and opportunities for the market.

Furthermore, it provides information about market development and future trends useful for organizations, including distributors and exporters. It analyzes critical market players' revenue, product portfolio and recent activities. It further includes strategies adopted by emerging market players with strategic recommendations for new market entrants. Outright information is provided in the report, consisting of historical and current market size, including the market's future potential.

The report will also help inform market players and new entrants about the production and export of goods and services to original equipment manufacturers. The market is segmented based on technology, components, applications, and end user. A geographical market analysis is provided for all the major segments. The report offers a country-level analysis of the market to understand major components better.

Report Includes

208 data tables and 22 additional tables
An overview of the global market for single-use technologies for the biopharmaceutical industry
Estimation of the market size and analyses of global market trends, with data from 2018-2021, with projections of compound annual growth rates (CAGRs) through 2026
Discussion on present and future opportunities and key factors influencing the single-use technologies and bioreactors for pharmaceuticals
Quantification of market applications, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives and anticancer drugs
Highlights of the market potential for single-use technologies for the biopharmaceutical industry, based on technology, component, application, end user, and region
Description of biologics manufacturing process including upstream and downstream processing and cell harvesting and clarification, and information on single-use technology (SUT)
Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast, and assessment of new developments in the industry
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
Company profiles of major players, including Merck KGaA, Thermo Fisher Scientific Inc. , General Electric Co. , Danaher Corp. , and Sartorius AG

Single-use bioreactor technology has gained considerable importance in biotechnology manufacturing over the years. Several single-use options are available. Scalability is the biggest limitation. The industry's willingness to use single-use bioreactors is influenced by production parameters, product value and development time. It takes more time to complete comparative studies with conventional stainless-steel bioreactors as the rate of implementation is lower than that of acceptance, thus making single-use technology highly desirable in the biopharmaceutical industry.

However, more clarity and understanding regarding the regulatory requirements for single-use bioreactor technology are needed. For example, U. S. FDA regulations for the Cord Blood Registry (CBR) do not explicitly mention single-use bioreactor technology, even though a large number of Investigational New Drug (IND) programs have been approved by the FDA using such systems.

The major factors influencing the growth of the market include increasing demand for personalized medicine, extensive ongoing development efforts, a strong product portfolio, and large application areas for single-use systems. Additionally, lower cost and reduction in the time necessary in the biomanufacturing process when using single-use technology are further driving the growth of the market.

The drug development rate has increased rapidly with the increasing demand for personalized medicines. This has, in turn, increased the demand for single-use technology to avoid the risk of contamination.

A strong product portfolio is further fueling the growth of the market during the forecast period. There are several companies that are offering single-use technologies, such as Thermo Fisher Scientific Inc. , Danaher Corp. , Sartorius AG, General Electric Co. , and PendoTECH LLC. PendoTECH LLC is focused on the development of pressure sensors used to measure static and dynamic pressure of gases and liquids in biopharmaceutical processes.

It also provides a wide range of single-use products such as single-use rotary flowmeters, single-use ultrasonic flowmeters and a compact low-flow ultrasonic flow meter with are usable fluid path.

Key Topics Covered:

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing this Study
What's New in this Update
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Custom Research
Related Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Historical Analysis: the Foundation for Single-Use Technology
Description of Current Market Trends
Raw Material Analysis
Biopharmaceutical Manufacturing Process
Market Dynamics

Chapter 4 Biologics Process Development Pathway and Application of Single-Use Technologies

Biologics Manufacturing Process
Upstream Processing
Cell Harvesting and Clarification
Downstream Processing
Single-Use Technology (Sut)
Process Development Period
Process Development Cost

Chapter 5 Covid-19 Impact on Market

Chapter 6 Market Breakdown by Technology

Single-Use Bioreactors
Wave-Induced Motion Single-Use Bioreactors
Stirred Single-Use Bioreactors
Single-Use Reactors With Vertically Oscillating Perforated Disc
Single-Use Bubble Column
Single-Use Hybrid Reactor
Mixing, Storage and Filling Systems
Filtration Systems
Dead-End Filtration
Tangential Flow Filtration (Tff)
Centrifugal Pumps
Chromatography Systems
Affinity Chromatography
Ion Exchange Chromatography
Hydrophobic Interaction Chromatography
Mixed-Mode Chromatography
Freeze and Thaw Systems
Isolators
Control Systems
Flow Measurement Systems
Temperature Measurement Systems
Ph Measurement Systems
Concentration Analyzer

Chapter 7 Market Breakdown by Single-Use Component

Single-Use Sensors
Advantages
Piezo Sensors
Mechanical Sensors
Electrical Sensors
Optical Sensors
Electrochemical
Impedance
Amperometric
Tubing
Connectors
Transfer Systems
Sampling Systems
Media Bags
2D Bags
3D Bags
Bioprocess Containers
Filter Cartridges
Other Single-Use Products

Chapter 8 Market Breakdown by Application

Monoclonal Antibodies
Polyclonal Antibodies
Vaccines
Blood Derivatives
Anticancer Drugs
Recombinant Proteins
Gene Therapy Drugs
Stem Cell and Other Cell Therapies

Chapter 9 Market Breakdown by End-user

Biopharmaceutical Companies and Contract Manufacturers
Labs and Pathology Products
Research Institutes and Academia

Chapter 10 Market Breakdown by Region

North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World (Row)
Latin America
Middle East and Africa

Chapter 11 Patent Review

Patent Analysis

Chapter 12 Competitive Analysis and Market Opportunities

Key Supplier and Manufacturer Positioning
Merck Kgaa
Thermo Fisher Scientific Inc.
General Electric Co.
Danaher Corp.
Sartorius AG
Key Strategy Analysis
Mergers and Acquisitions
Geographical Expansion
New Product Developments and Technologies
Product Launches
Industry Developments
Company Developments

Chapter 13 Company Profiles

Aber Instruments Ltd.
Adolf Kunher AG
Advantapure Inc.
Applikon Biotechnology B.V.
Aucteq Biosystems
Biopharma Dynamics Ltd.
Broadley-James Corp.
Cellexus Ltd.
Cellon S.A.
Celltainer Biotech Bv
Cercell Aps
Charter Medical Ltd.
Colder Products Co. (Cpc)
Cole-Parmer Instrument Co. LLC
Colly Flowtech Ab
Compagnie De Saint-Gobain S.A.
Corning Inc.
Danaher Corp.
Distek Inc.
Emerson Electric Co.
Entegris Inc.
Eppendorf AG
Equflow Bv
Esco Group
Esi Technologies Ltd.
General Electric Co.
Holland Applied Technologies Inc.
Levitronix GmbH
Malema Engineering Corp.
Meissner Filtration Products Inc.
Merck Kgaa
Mettler-Toledo LLC
Omnibrx Biotechnologies Pvt. Ltd.
Optek-Danulat GmbH
Parker Hannifin Corp.
Pendotech LLC
Perfusecell A/S
Pierre Guerin Sas
Presens Precision Sensing GmbH
Renolit Group
Repligen Corp.
Syntegon Technology GmbH
Sartorius AG
Sentinel Process Systems Inc.
Sia Biosan
Solida Biotech GmbH
Synthecon Inc.
Terumo Cardiovascular Group
Thermo Fisher Scientific Inc.
Trace Analytics GmbH
Vwr International LLC
Watson-Marlow Fluid Technology Group
W.L. Gore & Associates Inc.

Chapter 14 Appendix: Abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/xzilpr

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets